Legal Affairs
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators and investors wrapped up 2025 on a high note, with federal policy breakthroughs and corporate maneuvers signaling sustained growth potential across Cannabis & Psychedelics. Over the past two weeks, President Trump's ...
Texas Awards $50M Grant to Spearhead Ibogaine Trials
AUSTIN – The Texas Health and Human Services Commission has granted $50 million to a statewide consortium led by UTHealth Houston and the University of Texas Medical Branch at Galveston, marking the formal launch of ...
Vireo Growth Acquires PharmaCann Colorado Assets
DENVER – Vireo Growth Inc. reached an agreement with PharmaCann Inc. to buy its 17 operational dispensaries and related assets in Colorado for roughly $49 million in company shares, a move that bolsters Vireo's retail ...
Gallup Reveals First Dip in Years for Cannabis Legalization Public Support
LOS ANGELES – A fresh Gallup survey reveals that 64% of American adults now back making Cannabis use legal, a figure that marks the first decline in overall support since 2019 and pulls back from ...
New York Updates Cannabis Packaging, Labeling, and Advertising Regulations
NEW YORK – The New York State Cannabis Control Board finalized amendments to its packaging, labeling, marketing, and advertising regulations, marking a significant step in refining the state's adult-use Cannabis market. The changes aim to ...
Planet 13 Reports Q3 2025 Financial Results
LAS VEGAS – Planet 13 Holdings Inc., a multistate Cannabis operator with flagship operations in Nevada and Florida, disclosed a $44 million net loss for the third quarter, reflecting the toll of compressed prices, softening ...
Glass House Brands Reports Q3 2025 Financial Results
LONG BEACH – Glass House Brands Inc. disclosed third-quarter 2025 earnings that showed a marked slowdown in sales and profitability, chalked up to deliberate shifts in its labor strategy. The company posted revenue of $38.4 ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators and investors wrapped up 2025 on a high note, with federal policy breakthroughs and corporate maneuvers signaling sustained growth potential across Cannabis & Psychedelics. Over the past two weeks, President Trump's ...
Texas Awards $50M Grant to Spearhead Ibogaine Trials
AUSTIN – The Texas Health and Human Services Commission has granted $50 million to a statewide consortium led by UTHealth Houston and the University of Texas Medical Branch at Galveston, marking the formal launch of ...
Vireo Growth Acquires PharmaCann Colorado Assets
DENVER – Vireo Growth Inc. reached an agreement with PharmaCann Inc. to buy its 17 operational dispensaries and related assets in Colorado for roughly $49 million in company shares, a move that bolsters Vireo's retail ...
Mississippi Expands Medical Cannabis Program and Research Capabilities
LOS ANGELES- In 2022, Mississippi passed a restrictive medical cannabis program. Two new bills aimed at enhancing patient access to cannabis care and expanding research capabilities will take effect on July 1. Senate Bill 2857: ...
New Hampshire Lawmakers Near Compromise on Adult-Use Cannabis Legalization
LOS ANGELES- New Hampshire lawmakers in the House and Senate are reportedly close to reaching a compromise on a cannabis legalization bill, according to the New Hampshire Bulletin. With the legislative session ending on Thursday, ...
Proposed Amendments to Cannabis Law in Canada Aim to Ease Regulatory Burden
LOS ANGELES- The Canadian government has proposed a series of amendments to federal cannabis regulations to alleviate some of the regulatory burdens faced by producers and distribution companies. These changes aim to streamline processes ranging ...
Nebraska Advocates Push for Medical Cannabis Initiative Signatures
LOS ANGELES- Nebraskan advocates are urgently working to collect signatures for their medical cannabis initiative to be included on this year’s ballot. The advocacy group Nebraska for Medical Marijuana (NMM) is appealing to supporters to ...
Florida Governor Vetoes Hemp Regulations Package
NEW YORK- Florida Governor Ron DeSantis vetoed a legislative package aimed at banning products containing hemp-derived delta-8 THC and other intoxicating cannabinoids, according to CBS News. The vetoed legislation, Senate Bill 1698, sought to regulate ...
Michigan Surpasses California in Legal Cannabis Sales
LOS ANGELES- In an unexpected development within the cannabis industry, Michigan has overtaken California in the number of legal cannabis products sold. This shift, initially reported by SF Gate, marks a significant change in market ...
THCA Hemp Flower Prices Maintain Parity with Cannabis in Several States
LOS ANGELES- A new report by Hemp Benchmarks, shared with Green Market Report, indicates that wholesale prices for THCA hemp flower have maintained parity with cannabis in several regulated adult-use state markets, positioning it as ...
Michigan Surpasses California in Monthly Cannabis Sales for First Time
LOS ANGELES- Michigan sold more cannabis products in March this year than any other state, surpassing California for the first time in monthly sales, according to BDSA data outlined in an SF Gate report. Michigan ...
Rhode Island Launches Free Cannabis Industry Training Program
LOS ANGELES- The Rhode Island Department of Labor, in collaboration with the Community College of Rhode Island (CCRI), will offer a free cannabis training program to a select group of students. This initiative aims to ...
California Reinvests Cannabis Tax Revenue to Support Communities
LOS ANGELES- The California Community Reinvestment Grants (CalCRG) Program has announced over $45 million in grants for Fiscal Year 2023-24, aiming to uplift communities impacted by the War on Drugs. This initiative represents a significant ...
South Dakota Adult-Use Cannabis Initiative to Appear on 2024 Ballot
NEW YORK- South Dakota voters will have another opportunity to decide on the legalization of adult-use cannabis. Initiated Measure 29, which aims to legalize the recreational use, possession, and distribution of cannabis, will be on ...
Canopy Growth to Fully Acquire Acreage Holdings in Strategic Expansion
LOS ANGELES- Canadian cannabis company Canopy Growth has agreed to acquire all issued and outstanding Class E shares of Acreage Holdings, a U.S.-based multistate cannabis operator. This acquisition is part of Canopy's broader strategy to ...
Vermont Medical Cannabis Patient Appeals Denial of Unemployment Benefits to State Supreme Court
LOS ANGELES- A Vermont man is appealing the denial of a portion of his unemployment benefits to the state Supreme Court after being terminated from his job for using medical cannabis. Ivo Skoric, 59, who ...
House Approves Amendments to Authorize Medical Cannabis Recommendations for Veterans and Support Psychedelics Research
LOS ANGELES- The U.S. House of Representatives has approved amendments to a significant spending bill, enabling Department of Veterans Affairs (VA) doctors to issue medical cannabis recommendations to military veterans and support research into psychedelics. ...
DEA Proposal to Reclassify Cannabis Generates Strong Public Response
LOS ANGELES- Following the submission of a proposal by the Drug Enforcement Administration (DEA) on May 21, a 60-day public comment period was initiated, set to conclude on July 22. In the first 15 days, ...
Beckley Psytech Launches Study on Neurophysiological Effects of Synthetic 5-MeO-DMT
LOS ANGELES- Beckley Psytech, a private psychedelics medicine company, announced on Monday the commencement of a new research study investigating the neurophysiological effects of BPL-003, its novel synthetic intranasal formulation of 5-MeO-DMT, on the human ...
CannMed24 Event Review: 12 Things You Missed at CannMed 24
NEW YORK-CannMed 24 has set a new benchmark in the cannabis industry, offering unparalleled insights, networking opportunities, and a unique experience. Here are a dozen highlights certain to stir up a whole bunch of FOMO ...
Filament Health Receives Authorization for Phase 2 Clinical Trial of Psilocybin for MAUD Treatment
LOS ANGELES- Filament Health, a psychedelic drug development company, has received authorization from Health Canada and the United States Food and Drug Administration (FDA) to conduct a Phase 2 clinical trial of its botanical psilocybin ...
Japan to Accept Public Comments on Cannabis Reform Bill
WORLD- The Japanese government announced on May 30 that it will begin accepting public comments on its cannabis reform bill, which includes potential measures to loosen restrictions on processing CBD in food products. This move ...
Few Pardons Issued for Cannabis Crimes in Canada Since 2019 Reforms
LOS ANGELES- Despite the federal government’s estimate that 10,000 Canadians would be eligible for conviction relief following the legalization of cannabis in 2018, only 845 pardons have been granted since 2019. Data from the Parole ...
South Africa Legalizes Cannabis for Personal Use
LOS ANGELES- South Africa has become the first country in Africa to legalize cannabis for personal use. The Cannabis for Private Purposes Act was signed into law by President Cyril Ramaphosa on May 28, just ...
Red Light Holland Completes Initial Phase of Psilocybin Extraction
LOS ANGELES- Red Light Holland Corp. a company specializing in the production and sale of functional mushrooms and psilocybin truffles, announced the successful completion of the first phase of psilocybin extraction. This milestone was achieved ...
Optimi Health to Export MDMA and Psilocybin Capsules to Australia
LOS ANGELES- a Health Canada licensed GMP psychedelics pharmaceutical manufacturer, announced it has received an import permit from Mind Medicine Australia (MMA) to supply its GMP MDMA and psilocybin capsules to approved psychiatrists under Australia’s ...
DeSantis Expected to Veto Hemp Bill Limiting THC Levels
LOS ANGELES- Florida Governor Ron DeSantis is anticipated to veto Senate Bill 1698, which aims to restrict the sale of hemp-derived products containing delta-8 THC, delta-9 THC, and delta-10 THC. The bill has faced significant ...
FDA Advisory Panel to Review MDMA for PTSD Treatment
LOS ANGELES- Earlier today, staff from the U.S. Food and Drug Administration (FDA) expressed concerns regarding the interpretation of data from trials on the psychedelic drug MDMA for treating post-traumatic stress disorder (PTSD). These concerns ...
